BioSynTech Malaysia Group Sdn Bhd
199701004244 (419740-A)
No 3-2, 3rd Floor,
N-Tatt Building,
Jalan TP 5, Taman Perindustrian UEP,
47600 Subang Jaya, Selangor
Tel: +6 03 7886 2682
WhatsApp/Call: +6 016 216 0492
E : info@bstmgroup.com
Antibody specificity is of pivotal importance in clinical diagnosis, OriGene has developed UltraMAB™, a class of monoclonal antibodies of ultra specificity for such rigorous requirement. ...
The enzyme-linked immunosorbent assay (ELISA) has become a fundamental application in diagnostic and biomedical research labs, demonstrating specificity, sensitivity, and reproducibility across a range of applications. Despite its ability to generate quick results and automate at high throughputs, its success relies on careful technique, sound...
Choose over 600 high quality antibodies to a variety of human and animal targets....
Learn About PathPlex® panels Request Your Quote ...
Santa Cruz Biotechnology offers over 175,000 Specialty Biochemicals under the ChemCruz™ brand!. Their 𝐏𝐫𝐨𝐭𝐞𝐢𝐧-𝐈𝐧𝐭𝐞𝐫𝐚𝐜𝐭𝐢𝐧𝐠 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬, 𝐀𝐜𝐭𝐢𝐯𝐚𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐒𝐮𝐛𝐬𝐭𝐫𝐚𝐭𝐞𝐬 are designed to work seamlessly with our primary antibodies to study protein function. More generalized chemicals such as 𝐏𝐫𝐞𝐩𝐚𝐫𝐞𝐝 𝐁𝐮𝐟𝐟𝐞𝐫𝐬, 𝐒𝐮𝐫𝐟𝐚𝐜𝐭𝐚𝐧𝐭𝐬 𝐚𝐧𝐝 𝐒𝐨𝐥𝐯𝐞𝐧𝐭𝐬 are suitable for everyday...
anta Cruz Biotechnology (SCBT) is the #1 source of Primary Antibody Conjugates. Conjugated monoclonal primary antibodies for direct Western blots or Staining eliminates the need for secondary antibody. Directly conjugated antibodies are accurate and reliable research tools for a broad range of applications....
Are you still measuring prorenin the old fashioned way? Now there is an alternative to lengthy assay protocols that inaccurately detect prorenin by activation and angiotensin generation....
MCE (MedChemExpress) provides a wide range of lifescience biochemicals, including more than 25,000 bioactive compounds, dye reagents, peptides and natural compounds for laboratory and scientific use....
mmune checkpoints are inhibitory proteins that control the strength and duration of T-cell responses. Tumor cells take advantage of these pathways to escape immune surveillance. ...
Since the COVID-19 pandemic began a range of SARS-CoV-2 variants have emerged across the world. Most attention has been drawn on fast-spreading variants, recently identified B.1.1.7 (UK), B.1.351 (South Africa) and P.1 (Brazil). Scientists suspect that the variants’ particular patterns of mutations have the potential...
